Nothing Special   »   [go: up one dir, main page]

AU2007202009B2 - A Pulsatile Control System for a Rotary Blood Pump - Google Patents

A Pulsatile Control System for a Rotary Blood Pump Download PDF

Info

Publication number
AU2007202009B2
AU2007202009B2 AU2007202009A AU2007202009A AU2007202009B2 AU 2007202009 B2 AU2007202009 B2 AU 2007202009B2 AU 2007202009 A AU2007202009 A AU 2007202009A AU 2007202009 A AU2007202009 A AU 2007202009A AU 2007202009 B2 AU2007202009 B2 AU 2007202009B2
Authority
AU
Australia
Prior art keywords
pump
speed
electrical current
induced electrical
cardiac cycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2007202009A
Other versions
AU2007202009A1 (en
Inventor
Colin Neville Sutton
John Woodard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thoratec LLC
Original Assignee
Thoratec LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006902428A external-priority patent/AU2006902428A0/en
Application filed by Thoratec LLC filed Critical Thoratec LLC
Priority to AU2007202009A priority Critical patent/AU2007202009B2/en
Publication of AU2007202009A1 publication Critical patent/AU2007202009A1/en
Assigned to THORATEC CORPORATION reassignment THORATEC CORPORATION Request for Assignment Assignors: VENTRASSIST PTY LTD
Application granted granted Critical
Publication of AU2007202009B2 publication Critical patent/AU2007202009B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

A system for controlling the speed of a rotary blood pump. The system oscillates the speed of the pump to produce pulsed pressure at the outlet of the pump. The speed is oscillated synchronously with the natural cardiac cycle. The natural cardiac cycle is determined using a pulsatility index calculated from the back EMF produced by the pump. -2/4 Heart Circulatory GUI system Rotary seedsga Controller Power Blood Supply Pump v Back EMF Fig. 2

Description

P20513AUOI AUSTRALIA Patents Act 1990 COMPLETE SPECIFICATION ORIGINAL Name of Applicant: VENTRASSIST PTY LTD Actual Inventors: Colin Sutton John Woodard Address for Service: PAPPAS IP Patent & Trade Mark Attorneys 8/24A Musgrave Street Mosman NSW 2088 Invention Title: A Pulsatile Control System for a Rotary Blood Pump Details of Associated Provisional Application: Application No. 2006902428 Filed on 9 May 2006 The following statement is a full description of this invention, including the best method of performing it known to us: 2 A PULSATILE CONTROL SYSTEM FOR A ROTARY BLOOD PUMP Field of the Invention 5 The field of the present invention relates to pulsatile control systems for rotary blood pumps. Background of the Invention Blood pumps have been commonly used to provide mechanical support or 10 assistance to the left ventricles of patients. Typically, the left ventricle is responsible for pumping blood into the aorta and throughout a majority of the patient's body. Ventricular assistance has been previously been provided by an implanted blood pump, such as the VentrassistTM rotary blood pump described in US Patent 6,227,797- Watterson et al. These blood pumps generally pump blood in parallel to the normal circulatory 15 system by removing blood directly form the left ventricle and pumping into a portion of the aorta. Generally when such a blood pump is implanted, blood may flow or be pumped by both the left ventricle and the blood pump. Previously, these rotary blood pumps have been operated at relatively constant speeds because of the design of the pump. In the past, some efforts have been made to 20 adjust the pumping speed to compensate for under or over-pumping of the left ventricle. However, these types of control systems often fail to sufficiently mimic the natural cardiac cycle of a patient in which the circulatory system experiences a pulsed blood flow and/or pressure.
3 Previously, older blood pumps relied on compression type mechanisms to provide mechanical assistance to the heart and circulatory system. These compression type blood pumps generally include a sac member and two one-way valves arranged so as to provide pulsatile outflow to the patient's circulatory system. These devices are 5 generally prone to mechanical failure as well as thrombogenesis or blood clotting occurring around the valves. An example of these types of pulsatile blood pumps is described within US Patent 5,728,069 - Montevecchi et al. These types of cardiac assist devices are commonly classified as first generation assist devices. US Patent 6,547,753 - Plunkett et al describes a heart-lung machine that includes 10 a blood pump. The described heart-lung machine wherein the steady state blood flow exiting the artificial lung is induced to become pulsatile by the use of an elastic bladder. However, the inclusion of a compressible bladder in this system may also be a location of potential thrombogenesis and is generally not preferred for patient safety. US Patent 4,296,500 - Monties et al describes a rotary blood pump that may 15 provide a pulsatile flow by the use of a rotary piston shaped like a eccentric ovoid. The rotation of the rotary piston in this pump causes the blood passing through the pump to be ejected in a pulsed pattern whilst the piston is rotated at a steady rate. The main disadvantage with this system it that the depicted configuration may subject the blood to relatively high pressures at the times of ejection and may cause haemolysis to occur the 20 blood. US Patent 4,957,504 - Chardack discloses a rotary continuous flow blood pump in which the pumping speed is ramped between two preferred settings and is synchronised with either ECG data or other data from additional implanted sensors. The main 4 disadvantage with this arrangement is that the use of additional implanted sensors increase the patient's risk of infections, complications and blood clotting. The present invention aims to or at least address or ameliorate one or more of the disadvantages associated with the abovementioned prior art. 5 Summary of the Invention According to a first aspect the present invention consists in a system for controlling the speed of a rotary blood pump, comprising: a controller configured to receive as input two 10 motor speed settings and an induced electrical current produced by the pump, calculate a pulsatility index indicative of a diastole or systole phase of a cardiac cycle from the induced electrical current, and send a control signal based on the computed pulsatility index for varying the pump speed between the two speed settings so as to synchronize motor speed with the occurrence of the diastole or systole phase of the cardiac cycle. 15 Preferably the controller is configured to operate the pump at a single speed set-point with fluctuations about the set-point due to the natural cardiac motion of the heart Preferably the pump is a ventricle assist device. Preferably the induced electrical current is a back EMF signal, Preferably the induced electrical current is generated from relative movement between a 20 rotor part of the pump and a stator part of the pump. Preferably the pump speed is varied so as to prevent ventricular collapse or maximize pumping efficiency.
5 According to a second aspect the present invention consists in a method for controlling the speed of a rotary blood pump, comprising: providing two motor speed settings; sensing an induced electrical current produced by the pump; 5 determining a parameter indicative of a diastole or systole phase of a cardiac cycle from the sensed electrical current; and varying the pump speed between the two speed settings based on the determined parameter so as to synchronize motor speed with the occurrence of the diastole or systole phase of the cardiac cycle. 10 Preferably the pump is a ventricle assist device. Preferably the induced electrical current is a back EMF signal. Preferably the induced electrical current is generated from relative movement between a rotor part of the pump and stator part of the pump. Preferably the pump speed is varied so as to prevent ventricular collapse or maximize 15 pumping efficiency. Preferably the parameter includes a pulsatility index. According to a third aspect the present invention consists in a system for controlling the speed of a rotary blood pump having a motor, comprising: a controller configured to receive as input two motor speed settings and a signal produced by the pump motor, 20 calculate a pulsatility index indicative of a diastole or systole phase of a cardiac cycle from the signal, and send a control signal based on the computed pulsatility index for varying the pump speed between the two speed settings so as to synchronize motor speed 6 with the occurrence of the diastole or systole phase of the cardiac cycle. Preferably the signal is an induced electrical current. 5 Preferably the induced electrical current is a back EMR According to a fourth aspect the present invention consists in a method for controlling the speed of a rotary blood pump having a motor, comprising: providing two motor speed settings; 10 sensing a signal produced by the pump motor; determining a parameter indicative of a diastole or systole phase of a cardiac cycle from the sensed signal; and varying the pump speed between the two speed settings based on the determined parameter so as to synchronize motor speed with the occurrence of the diastole or systole 15 phase of the cardiac cycle. Preferably the signal is an induced electrical current. Preferably the induced electrical current is a back EMF. Preferably the pump speed is varied so as to prevent ventricular collapse or maximize pumping efficiency. 20 Preferably the pump speed is varied so as to prevent ventricular collapse or maximize pumping efficiency.
7 Brief Description of the Drawings Embodiments of the present invention will now be described with reference to the accompanying drawings wherein: Fig. I depicts a cross sectional view of a preferred rotary blood pump to be used with 5 embodiments of the present invention; Fig. 2 depicts a diagrammatic representation of a first preferred embodiment of the present invention; Fig. 3 depicts a flowchart of the first preferred embodiment; and Fig. 4 depicts a diagranmatic representation of a second preferred embodiment of the 10 present invention. Brief Description of the Preferred Embodiments A first preferred embodiment of the present invention is depicted in Figs. 2 & 3. The first embodiment includes a controller 10 controlling and powering an implanted 15 rotary blood pump 1. The most preferred rotary blood pump is depicted in Fig. 1. The most preferred rotary blood pump 1, as depicted in Fig. 1, includes a hydrodynamically suspended impeller 2 comprising a set of four blades 5 joined by supports in a generally circular formation. Preferably, the impeller 2 is hydrodynamically suspended within a pumping cavity 6 within the pump housing 7. When in use, the 20 impeller 2 is magnctically urged to rotate by the sequential firing of two sets of three stator coils 8 mounted in or on the housing above and below the impeller 2. The stator coils 8 interact with permanent magnets within each blade 5 to provide a torque force. The blood enters via the inlet 3 at the top of the pump 1 and is propelled by centrifugal force applied by the rotating impeller 2 to the outlet 4. The hydrodynamic suspension of 8 the impeller 2 is achieved by the outer surfaces of the blades 5 being slightly inclined to produce a fluid restriction when rotated within the cavity 6. The most preferred rotary blood pump for use with the present invention or embodiments is described in detail in US Patent 6,227,797 - Watterson et al and the description of this US Patent is herein to be 5 included within the present specification. The most preferred rotary blood pump may also include a magnetically suspended or levitated impeller. The first preferred embodiment of the present invention, as depicted in Fig. 2, includes an implanted rotary blood pump 1 powered and controlled by an external 10 controller 10. Preferably, the rotary blood pump I is connected in parallel fluid communication with the circulatory system of the patient. In Fig. 2, the inflow or inlet of the pump 1 is connected by cannulation to natural heart 17 of the patient via the left ventricle. The normal patient circulatory system is not disconnected or interrupted by the implantation of the pump I and the heart 17 may continue to pump blood around the 15 remainder of the circulatory system 20. The rotary blood pump 1 has its outflow cannula preferably connected to a portion of the aorta which is included within the circulatory system 20. When the pump 1 is operated under steady state conditions, the pump 1 continuously offloads blood from the left ventricle of the heart 17 and propels the blood into the another portion of the circulatory system such as the aorta at a relatively steady 20 rate. Relatively steady state generally means a situation where the pump is operated at a single speed set-point by the controller but the natural cardiac motion of the heart fluctuates the actual pumping speed experienced by the pump. Thereby, the pump 1 assists a patient's heart and this system is particularly useful with patients suffering 9 congestive heart failure which is mainly attributed to failure or insufficiency of the left ventricle. JIn the depicted first preferred embodiment, the pump 1 is controlled and powered by the controller 10. The controller 10 regulates the speed 12 of the pump 1 via electrical 5 signals transmitted by a percutaneous lead extending through the skin layer 15 of an implanted patient. Please note that electrical signals may be transmitted by alternate means including transcutaneous energy transmission systems (commonly referred to as 'TETS') The controller 10 also preferably receives data back from the rotary blood pump 1. The information received may include back EMF data or signals which are preferably 10 generated to the motion of the DC brushless motor design which is inherently included within the design and configuration of the most preferred rotary blood pump. Preferably, when the impeller 2 rotates within the cavity 6, the permanent magnets within the blades 5 pass the respective stator coils 8 and induce an electrical current in said stator coils 8. This induced electrical current is detected and measured by controller 15 10 as a back EMF signal 11. The back EMF II signal or data may allow the controller 10 to accurately predict the speed of rotation of the impeller 2 as well as the position of the blades 5 of the impeller 2 at any given instance. The controller 10 receives electrical power from an external power supply 14 and uses this supplied electrical power to power the rotary action of the pump 1. The power 20 supply 14 may be a mains power connection or a set of batteries. The controller 10 may also be able to be selectively connected to a personal computer (not shown) and this personal computer may run a graphical user interface 13 software (herein referred to as 'GUI'). The GUI 13 may be utilised by a patient, doctor, clinician or nursing staff to display information and statistics about the pump I and the 10 condition of the patient which is received from the controller 10. The GUI 13 may also be used to input data, operating parameters and commands into the controller 10. In this first preferred embodiment, the doctor or clinician may be able to manually enter operating parameters for the pump 1 into the GUI 13 and the GUI 13 may then program these 5 parameters into the controller 10. The controller 10 will then operate the pump 1 within these parameters. Fig. 3 depicts a flowchart of a preferred decision tree followed by the controller 10. The flowchart starts at the first step 20 and then detects 21 the back EMF 11 received from the pump 1. The back EMF 11 is generally indicative of the pumping speed of the 10 pump 1. The controller 1 then proceeds to the step 22, wherein the controller 10 calculates a pulsatility index from the speed of pump I determined from back EMF 11 data. The controller 10 may then determine the current stage at which the natural heart 17 is in terms of its cardiac cycle 23. Specifically, it may be possible for the controller 10 to determine whether the heart 17 is currently in diastole or systole based calculation and 15 derivation of the pulsatility index. The final step 24 for the controller 10 is to oscillate the pumping speeds preferably between two predetermined speed values and to simultaneously synchronise these speed oscillations with the cardiac cycle or timing of the heart las determined in the earlier step 23. Preferably, the oscillations may be timed so as to either prevent ventricular collapse or 20 to maximum pumping efficiency. The pumping efficiency may be maximised as the rotary blood pump 1 may potentially be periodically at a higher speed setting, if the speed oscillations are properly timed. Preferably, the doctor or clinician may enter two preferred pump speeds for the controller 10 to oscillate between. These predetermined speed values are entered into the 11 GUI 13 in step 26, which may occur at anytime when the controller 10 is connected to the GUI 13. The GUI 13 then transmits the predetermined speed values to the controller 10 and these values are then recorded in the controller 10 in step 25. A second embodiment of the present invention as shown in Fig. 4, utilises an 5 impedance sensor 31 instead of back EMF data 11 as in the first embodiment The impedance sensor 31 measures the impedance across a portion of the heart. The variance in impedance is generally indicative of the breathing or respiration rate of the implanted patient. Therefore from the measured impedance the controller may be able to infer or derive the respiration rate of the patient and use this respiration rate as an analog of 10 instantaneous metabolic rate of the patient. Hence, the impedance sensor 31 may be measuring the minute volume or minute ventilation of the patient and allowing for calculations based on the amount of air in the lungs. An advantage of using an impedance sensor, is that such an impedance sensor does not need to contact blood, thus avoiding the problems of prior art sensors that do contact blood. 15 The controller 2 may then use the impedance signal (information) 18a to alter or adjust pump speed to properly meet the patient's metabolic demands. Additionally, the controller 2 may be able to adjust the timing of the oscillations of pump speed to match the beating of the heart or the respiratory needs of the patient. The above descriptions detail only some of the embodiments of the present 20 invention. Modifications may be obvious to those skilled in the art and may be made without departing from the scope and spirit of the present invention.

Claims (20)

1. A system for controlling the speed of a rotary blood pump, comprising: a controller configured to receive as input two motor speed settings and an induced electrical current produced by the purap, calculate a pulsatility index indicative of a diastole or systole phase of a cardiac cycle from the induced electrical current, and send a control signal based on the computed pulsatility index for varying the pump speed between the two speed settings so as to synchronize motor speed with the occurrence of the diastole or systole phase of the cardiac cycle.
2. The system of claim 1, wherein the controller is configured to operate the pump at a single speed set-point with fluctuations about the set-point due to the natural cardiac motion of the heart.
3. The system of claim 1, wherein the pump is a ventricle assist device.
4. The system of claim 1, wherein the induced electrical current is a back EMF signal.
5. The system of claim 1, wherein the induced electrical current is generated from relative movement between a rotor part of the pump and a stator part of the pump
6. The system of claim 1, wherein the pump speed is varied so as to prevent ventricular collapse or maximize pumping efficiency.
7. A method for controlling the speed of a rotary blood pump, comprising: providing two motor speed settings; 13 sensing an induced electrical current produced by the pump; determining a parameter indicative of a diastole or systole phase of a cardiac cycle from the sensed electrical current; and varying the pump speed between the two speed settings based on the dctcrmined parameter so as to synchronize motor speed with the occurronce of the diastole or systole phase of the cardiac cycle.
8. The method of claim 7, wherein the pump is a ventricle assist device.
9. The method of claim 7, wherein the induced electrical current is a back EMF signal.
10. The method of claim 7, wherein the induced electrical current is generated from relative movement between a rotor part of the pump and stator part of the pump.
11. The method of claim 7, wherein the pump speed is varied so as to prevent ventricular collapse or maximize pumping efficiency.
12. The method of claim 7, wherein the parameter includes a pulsatility index.
13. A system for controlling the speed of a rotary blood pump having a motor, comprising; a controller configured to receive as input two motor speed settings and a signal produced by the pump motor, calculate a pulsatility index indicative of a diastole or systole phase of a cardiac cycle from the signal, and send a control signal based on the computed pulsatility index for varying the pump speed between the two speed settings so as to synchronize motor speed with the occurrence of the diastole or systole phase of the cardiac cycle. 14
14. The system of claim 13, wherein the signal is an induced electrical current.
15. The system of claim 14, wherein the induced electrical current is a back EMF
16. A method for controlling the speed of a rotary blood pump having a motor, comprising: providing two motor speed settings; sensing a signal produced by the pump motor; determining a parameter indicative of a diastole or systole phase of a cardiac cycle from the sensed signal; and varying the pump speed between the two speed settings based on the determined parameter so as to synchronize motor speed with the occurrence of the diastole or systole phase of the cardiac cycle.
17. The method of claim 16, wherein the signal is an induced electrical current.
18. The method of claim 17, wherein the induced electrical current is a back EMF.
19. The system of claim 13, wherein the pump speed is varied so as to prevent ventricular collapse or maximize pumping efficiency.
20. The method of claim 16. wherein the pump speed is varied so as to prevent ventricular collapse or maximize pumping efficiency.
AU2007202009A 2006-05-09 2007-05-04 A Pulsatile Control System for a Rotary Blood Pump Ceased AU2007202009B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2007202009A AU2007202009B2 (en) 2006-05-09 2007-05-04 A Pulsatile Control System for a Rotary Blood Pump

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2006902428A AU2006902428A0 (en) 2006-05-09 A Pulsatile Control System for a Rotary Blood Pump
AU2006902428 2006-05-09
AU2007202009A AU2007202009B2 (en) 2006-05-09 2007-05-04 A Pulsatile Control System for a Rotary Blood Pump

Publications (2)

Publication Number Publication Date
AU2007202009A1 AU2007202009A1 (en) 2007-11-29
AU2007202009B2 true AU2007202009B2 (en) 2013-04-04

Family

ID=38787464

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007202009A Ceased AU2007202009B2 (en) 2006-05-09 2007-05-04 A Pulsatile Control System for a Rotary Blood Pump

Country Status (1)

Country Link
AU (1) AU2007202009B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111526899B (en) * 2017-12-19 2023-11-07 心脏器械股份有限公司 Heart rate measurement using blood pump impeller position

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152944A1 (en) * 2000-03-27 2004-08-05 Alexander Medvedev Chronic performance control system for rotodynamic blood pumps

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152944A1 (en) * 2000-03-27 2004-08-05 Alexander Medvedev Chronic performance control system for rotodynamic blood pumps

Also Published As

Publication number Publication date
AU2007202009A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
US7850594B2 (en) Pulsatile control system for a rotary blood pump
US20230414923A1 (en) Cardiac Pump With Speed Adapted for Ventricle Unloading
US10881772B2 (en) Generating artificial pulse
AU2018316543B2 (en) Blood pump
US8657875B2 (en) Method and apparatus for pumping blood
EP3131596B1 (en) Methods and systems for controlling a blood pump
US6139487A (en) Intracardiac pump device
JP2022552889A (en) Circulatory support system including controller and multiple sensors and method of operation thereof
AU2007202009B2 (en) A Pulsatile Control System for a Rotary Blood Pump
Shalli et al. Recent advances and patents on mechanical circulatory support devices

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: THORATEC CORPORATION

Free format text: FORMER APPLICANT(S): VENTRASSIST PTY LTD

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired